MedPath

taVNS for Upper Limb Rehabilitation

Early Phase 1
Completed
Conditions
Stroke
Interventions
Device: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training
Registration Number
NCT04129242
Lead Sponsor
Medical University of South Carolina
Brief Summary

This study explores the use of a new form of neuromodulation known as transcutaneous auricular vagus nerve stimulation (taVNS) which stimulates the ear. This stimulation will be delivered concurrently with upper limb motor rehabilitation training (3 days/week for 4 weeks) in chronic stroke patients. Patients will undergo a series of baseline assessments (including a brain scan), a 4-week course of motor rehabilitation, and post-assessments (including a second brain scan)

Detailed Description

This study aims to refine and develop closed loop taVNS, establish activity with key biomarkers, and show initial feasibility in a small clinical trial. For paired taVNS to succeed as a clinical treatment, it is critical to develop and refine a closed-loop taVNS platform that delivers stimulation concurrently during specific movements of the motor rehabilitation training.

Aim 1 develops this novel motion-gated closed-loop system that delivers taVNS in synchrony with specific upper limb motor activation (n=5) Aim 2 will combine the development of the closed-loop system with the investigator's mechanistic understanding to explore an open-label pilot trial (n=20) using closed-loop taVNS paired with task-specific training to determine the feasibility, safety, and potential effect size of this novel combination therapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • 18-80 years old
  • Ischemic or hemorrhagic stroke that occurred at least 6 months prior
  • Completed conventional rehabilitation therapy at least one month prior
  • Unilateral limb weakness with Fugl Meyer-Upper Extremity Scale score less than or equal to 58 (out of 66)
Exclusion Criteria
  • Primary intracerebral hematoma, or subarachnoid hemorrhage
  • Bilateral upper extremity weakness
  • Other concomitant neurological disorders affecting upper extremity motor function
  • Documented history of dementia before or after stroke
  • Documented history of uncontrolled depression or psychiatric disorder either before or after stroke which could affect their ability to participate in the experiment
  • Uncontrolled hypertension despite treatment, specifically SBP (Systolic Blood Pressure) / DBP (Diastolic Blood Pressure) >=180/100mmHg at baseline
  • Contraindicated for MRI scanning.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
"unpaired" taVNS + Task Specific TrainingTranscutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training-
"paired" taVNS + Task Specific TrainingTranscutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training-
Primary Outcome Measures
NameTimeMethod
Change in Fugl-Meyer Assessment of the Upper ExtremityMean change in FMA-UE score after 4 weeks of rehab, compared to baseline

The Fugl-Meyer Assessment of the Upper Extremity (FMA-UE) is a stroke rehabilitation assessment of arm/hand movement impairment. It is scored by assigning 30 items assessing voluntary arm/hand movements and 3 items assessing reflexes an ordinal rating (0=unable, 1=partial, 2=near normal), then summing the ratings to obtain a general statement of ability. Possible aggregate scores range from 0/66 to 66/66 points. Higher scores indicate greater levels of arm movement ability.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath